Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403310
Max Phase: Preclinical
Molecular Formula: C39H60N6O7
Molecular Weight: 724.94
Molecule Type: Small molecule
Associated Items:
ID: ALA3403310
Max Phase: Preclinical
Molecular Formula: C39H60N6O7
Molecular Weight: 724.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C
Standard InChI: InChI=1S/C39H60N6O7/c1-10-45(11-2)38(50)32(21-27-16-17-28-14-12-13-15-29(28)20-27)43-36(48)31(18-23(3)4)42-37(49)34(25(7)8)44-35(47)30(40)22-52-39(51)33(19-24(5)6)41-26(9)46/h12-17,20,23-25,30-34H,10-11,18-19,21-22,40H2,1-9H3,(H,41,46)(H,42,49)(H,43,48)(H,44,47)/t30-,31-,32-,33-,34-/m0/s1
Standard InChI Key: GVEODAKCAHCIIJ-LJADHVKFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 724.94 | Molecular Weight (Monoisotopic): 724.4523 | AlogP: 2.83 | #Rotatable Bonds: 20 |
Polar Surface Area: 189.03 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.83 | CX Basic pKa: 7.22 | CX LogP: 3.06 | CX LogD: 2.84 |
Aromatic Rings: 2 | Heavy Atoms: 52 | QED Weighted: 0.13 | Np Likeness Score: -0.16 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):